Citation map · Study

Selection strategies for newly registered blood donors in European countries.

14 references·4 citing·28 second hop

this work references cited by second hop

References

2002Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population642 cited
2004Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing535 cited
2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited
2010Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing287 cited
2011Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations198 cited
2007Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services154 cited
2003Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993–2001126 cited
2007Current risk for transfusion transmitted infections104 cited
2008Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey99 cited
2000False‐negative testing errors in routine viral marker screening of blood donors48 cited
2014Predonation screening of candidate donors and prevention of window period donations24 cited
2015First-time whole blood donation: A critical step for donor safety and retention on first three donations

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

References

Cited by